US Stock MarketDetailed Quotes
XCUR Exicure
- 3.1900
- +0.4600+16.85%
Trading Nov 14 15:14 ET
6.93MMarket Cap-708P/E (TTM)
3.3000High2.7100Low38.11KVolume2.7100Open2.7300Pre Close118.56KTurnover3.30%Turnover RatioLossP/E (Static)2.17MShares6.000052wk High4.29P/B3.69MFloat Cap1.440052wk Low--Dividend TTM1.16MShs Float576.0000Historical High--Div YieldTTM21.61%Amplitude1.4400Historical Low3.1110Avg Price1Lot Size
About Exicure Company
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Company Profile
SymbolXCUR
Company NameExicure
Listing DateJul 31, 2019
Founded2011
CEOMr. Paul Kang
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address2430 North Halsted Street
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60614
Phone1-847-673-1700
Websitehttp://www.exicuretx.com
Company Executives
- Name
- Position
- Salary
- Paul Kang
- Director, Chief Executive Officer and President
- 16.94K
- Jiyoung Hwang
- Director and Chief Financial Officer
- 16.97K
- Joshua Miller
- Chief Accounting Officer
- --
- Hojoon Lee
- Director
- 7.22K
- Dongho Lee
- Independent Director
- 7.22K
- Hyuk Joon Ko
- Independent Director
- 7.22K
- Eui Yull Hwang
- Independent Director
- --
- Minhee Eom
- Independent Director
- 5.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data